Clinical Trials Browser

Interventional × Kenny-Caffey syndrome, Type 1 × Clear all

NCT06458712 2026-05-27

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Phase 1 Recruiting

Kenny-Caffey syndrome, Type 1, Anophthalmia with pulmonary hypoplasia, Brain Neoplasms

NCT06152731 2025-09-17

HERO

Phase 2 Recruiting

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT07156253 2025-09-05

Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

BreastGynecologic

Kenny-Caffey syndrome, Type 1, Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05732129 2023-02-24

The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.

Phase 2 Unknown

Kenny-Caffey syndrome, Type 1

NCT02789332 2020-03-17

GeparOla

Phase 2 Completed

Kenny-Caffey syndrome, Type 1, Breast Neoplasms, Triple Negative Breast Neoplasms